• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[野生型胃肠道间质瘤的诊断与治疗]

[Diagnosis and treatment of wild-type gastrointestinal stromal tumors].

作者信息

Cao Hui, Wang Ming

机构信息

Department of General Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.

出版信息

Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Apr;17(4):312-6.

PMID:24760635
Abstract

Gastrointestinal stromal tumors(GIST) are the most common mesenchymal tumors of the gastrointestinal tract, and are mostly characterized by c-kit or PDGFRA gain-of-function mutation. About 10%-15% of GIST do not harbor any mutations in the c-kit and PDGFRA genes and are defined as wild-type GIST. There are significant differences in molecular mechanism and clinical characteristics between wild-type GIST and mutant GIST. Wild-type GIST should be considered as a family of diseases due to their extreme heterogeneity. Clinician should pay close attention to the diagnosis and treatment of wild-type GIST.

摘要

胃肠道间质瘤(GIST)是胃肠道最常见的间叶组织肿瘤,大多具有c-kit或血小板衍生生长因子受体A(PDGFRA)功能获得性突变的特征。约10%-15%的GIST在c-kit和PDGFRA基因中未发生任何突变,被定义为野生型GIST。野生型GIST与突变型GIST在分子机制和临床特征上存在显著差异。由于野生型GIST具有极高的异质性,应将其视为一类疾病。临床医生应密切关注野生型GIST的诊断和治疗。

相似文献

1
[Diagnosis and treatment of wild-type gastrointestinal stromal tumors].[野生型胃肠道间质瘤的诊断与治疗]
Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Apr;17(4):312-6.
2
[The importance of mutational status in prognosis and therapy of GIST].[突变状态在胃肠道间质瘤预后和治疗中的重要性]
Recenti Prog Med. 2015 Jan;106(1):17-22. doi: 10.1701/1740.18950.
3
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.在胃肠道间质瘤中,KIT/BRAF和PDGFRA/BRAF同时发生突变是罕见事件。
Oncotarget. 2016 May 24;7(21):30109-18. doi: 10.18632/oncotarget.8768.
4
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).KIT/PDGFRA 野生型(WT)胃肠道间质瘤(GIST)的分子生物学概述。
J Med Genet. 2013 Oct;50(10):653-61. doi: 10.1136/jmedgenet-2013-101695. Epub 2013 Jul 5.
5
Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.KIT/PDGFRA野生型胃肠道间质瘤的分类:对治疗的意义。
Expert Rev Anticancer Ther. 2015 Jun;15(6):623-8. doi: 10.1586/14737140.2015.1032941. Epub 2015 Apr 1.
6
Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.小儿KIT野生型和血小板衍生生长因子受体α野生型胃肠道间质瘤具有KIT激活,但在遗传进展机制方面与成人胃肠道间质瘤不同。
Cancer Res. 2007 Oct 1;67(19):9084-8. doi: 10.1158/0008-5472.CAN-07-1938.
7
Pathology of gastrointestinal stromal tumors.胃肠道间质瘤的病理学
Pathol Int. 2006 Jan;56(1):1-9. doi: 10.1111/j.1440-1827.2006.01924.x.
8
Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.KIT和PDGFRA野生型胃肠道间质瘤患者BRAF基因突变的检测
Virchows Arch. 2017 Jan;470(1):29-36. doi: 10.1007/s00428-016-2044-4. Epub 2016 Nov 18.
9
Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.血小板衍生生长因子受体-α通过稳定ETV1来调节KIT基因发生突变的胃肠道间质瘤细胞的增殖。
Gastroenterology. 2015 Aug;149(2):420-32.e16. doi: 10.1053/j.gastro.2015.04.006. Epub 2015 Apr 9.
10
[Drug resistance mechanism and new therapy strategy progression in targeted treatment of gastrointestinal stromal tumors].[胃肠道间质瘤靶向治疗中的耐药机制及新治疗策略进展]
Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Apr;17(4):321-5.